In addition, the expression levels of CK19, Ki67, and β-catenin were significantly associated with multiple clinicopathological features of HCC progression, offering new perspectives for multi-gene prognostic modeling and multi-pathway targeted therapy development. Here, MKI67 is linked to hepatocellular carcinoma.